Literature Monitoring for Pharmacovigilance
Open Access
- 25 March 2019
- journal article
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
- Vol. 7 (1), 31-43
- https://doi.org/10.30895/2312-7821-2019-7-1-31-43
Abstract
Literature monitoring is a complicated aspect of pharmacovigilance. The guidelines on good practice of pharmacovigilance of the Eurasian Economic Union recommend the using of a biomedical reference database containing the maximum number of sources for the monitored drugs, which necessitates the selection of such a database. The aim of the paper is to compare the coverage and functionality of international databases of medical publications recommended for monitoring literature within pharmacovigilance in terms of coverage and functionality. The paper analyzes the coverage and presents the comparison of the results of the search in the databases Embase®, MEDLINE® and eLibrary for 35 drugs. It have been shown that the search in the Embase® database provides the maximum number of sources. In addition, the paper shows the applicability special PV Wizard functionality which facilitate the building of search strategies with high recall, sensitivity and compliance.Keywords
This publication has 8 references indexed in Scilit:
- Preparation of a periodic safety update reportSafety and Risk of Pharmacotherapy, 2018
- Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in KuwaitSaudi Pharmaceutical Journal, 2016
- Safety Signal Detection: The Relevance of Literature ReviewDrug Safety, 2014
- Role of Pharmacovigilance in Drug DevelopmentEnliven: Pharmacovigilance and Drug Safety, 2014
- Safety Information From Spontaneous and Literature Adverse Reaction Reports: A ComparisonTherapeutic Innovation & Regulatory Science, 2013
- An evidence-based practice guideline for the peer review of electronic search strategiesJournal of Clinical Epidemiology, 2009
- A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodaroneBritish Journal of Clinical Pharmacology, 2004
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998